Dasatinib for Patients Achieving Complete Molecular Response for Cure D-NewS Trial

Exclusion Criteria

• •A case with the double cancer of the activity.
• •Women who are pregnant or breastfeeding.
• •female patient who there is not intention with an appropriate sterilization, or cannot use it during a study entry period
• •Patients with complications or a history of severe or uncontrolled cardiovascular failure following have a Myocardial infarction within 6 months have an Angina within 3 months have a Congestive heart failure within 3 months have a QTc interval of more than 450msec at baseline
• •A serious uncontrolled medical disorder that would impair the ability of the subjects to receive protocol therapy